Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT01107925
Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease
72
Enrollment(s)
6
Study location(s)
Interventional (Phase I)
Coronary Artery Disease
Unknown status
NCT01669213
Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension
100
Enrollment(s)
1
Study location(s)
Interventional (Not Applicable)
Hypotension
Shivering
Nausea and Vomiting
Vasopressor
Completed
NCT01004237
Additive Effects of Pravastatin and Valsartan
52
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Hypertension
High Cholesterol
Completed
NCT01463150
Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)
27
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Platelet Reactivity
Completed
NCT01175200
Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.
82
Enrollment(s)
1
Study location(s)
Interventional (Not Applicable)
Anti Platelet Effects
Completed
NCT01360437
Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention
44
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Coronary Artery Disease
Acute Coronary Syndrome
Completed
NCT01102491
Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee Arthroplasty
153
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Osteoarthritis, Knee
Terminated
NCT00910299
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
423
Enrollment(s)
27
Study location(s)
Interventional (Phase II)
Coronary Artery Disease (CAD)
101
102
103
104
105